Dr. Kholoud M. Abdulla, PhD.

Dr Kholoud is a distinguished expert in pharmacogenomics, clinical pharmacy and precision medicine, recognized as the first Qatari specialist in pharmacogenomics. She earned her Bachelor's degree in Pharmacy from Jordan University in 2006 and furthered her education with a Master's in Clinical Pharmacy from Queen’s University Belfast, UK, in 2014. In 2021, she successfully completed her PhD in Genomic and Precision Medicine.

Dr. Kholoud currently serves as an Acting Assistant Professor at the College of Pharmacy, Qatar University. Her work spans clinical research, translational science, and digital health innovation, with a focus on optimizing pharmacotherapy for neuropsychiatric disorders, oncology, and type 2 diabetes. Her research integrates pharmacogenomics, pharmacometabolomics, and AI-driven analytics to advance precision medicine approaches in mental health and chronic disease management.

She has secured multiple prestigious grants, including Path Towards Precision Medicine (PPM), Hamad Medical Corporation’s Internal Research Grant Cycle (IRGC), Qatar University’s National Capacity Building Program, and other competitive institutional research funding schemes. Dr. Kholoud leads several high-impact studies on the implementation of genomic-guided prescribing and personalized therapeutic strategies in real-world clinical settings.

Dr. Kholoud is the Chair of Qatar’s first HealthTech Innovation Hackathon, an initiative that promotes interdisciplinary collaboration and drives cutting-edge healthcare innovation. Her leadership in health entrepreneurship gained regional recognition after she won first place at the GCC Rowad Hackathon for her groundbreaking pharmacogenomics-based health tech solution. This success earned her the prestigious title of “Woman Entrepreneur of the Year” in 2024, celebrating her pioneering role in advancing precision medicine and digital health innovation in the region.

Beyond her research, Dr. Kholoud serves as a reviewer for high-impact peer-reviewed journals and contributes to advancing academic excellence and capacity building in genomic medicine.